Utah Medical Products UTMD Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity

Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity at other companies

Bank of Marin BancorpBMRC

-$7.43M-12,475%

VAL

Value LineVALU

-$621K—

JAK

Jakks PacificJAKK

$26.08M+3,723%

Corebridge FinancialCRBG

$52M-95.0%

Saga CommunicationsSGA

$3.34M+29.6%

Trustco Bank CorpTRST

-$4.47M+65.6%

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's adjustment to reconcile net income to cash provided by (used in) operating activity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's adjustment to reconcile net income to cash provided by (used in) operating activity?: Utah Medical Products (UTMD) reported adjustment to reconcile net income to cash provided by (used in) operating activity of $505K in Q1 2026.
How has Utah Medical Products's adjustment to reconcile net income to cash provided by (used in) operating activity changed year-over-year?: Utah Medical Products's adjustment to reconcile net income to cash provided by (used in) operating activity decreased by 64.5% year-over-year, from $1.42M to $505K.